-
Je něco špatně v tomto záznamu ?
Three-dimensional conformal external beam radiotherapy versus the combination of external radiotherapy with high-dose rate brachytherapy in localized carcinoma of the prostate: comparison of acute toxicity
Soumarová R, Homola L, Perková H, Stursa M
Jazyk angličtina Země Itálie
Typ dokumentu klinické zkoušky, srovnávací studie
- MeSH
- adenokarcinom radioterapie MeSH
- brachyterapie škodlivé účinky MeSH
- celková dávka radioterapie MeSH
- gastrointestinální trakt účinky záření MeSH
- konformní radioterapie škodlivé účinky MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory prostaty radioterapie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- urogenitální systém účinky záření MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Publikační typ
- klinické zkoušky MeSH
- srovnávací studie MeSH
AIMS AND BACKGROUND: Radiotherapy represents one of the basic therapeutic methods in treatment of localized carcinoma of the prostate. Optimal irradiation dose is the cornerstone of a successful treatment. Along with local control of the disease and overall survival of the patient, possible acute and long-term side effects need to be monitored very closely. METHODS: A non-randomized prospective study comparing the acute genitourinary and gastrointestinal toxicity in patients irradiated for localized carcinoma of the prostate. Fifty-seven patients were treated with three-dimensional conformal external beam radiotherapy alone, and in the second treatment arm a combination of external beam radiotherapy and high-dose rate brachytherapy was employed in 40 patients. RESULTS: Three-dimensional conformal external beam radiotherapy. Acute G1 genitourinary toxicity was recorded in 35.1% of patients, G2 in 22.8%, and G2-3 in one patient (1.7%). Acute gastrointestinal toxicity was experienced by 54.4% of patients, G1 in 28.1%, G2 in 17.5%, and G3 in 8.8%. Three-dimensional conformal external beam radiotherapy + brachytherapy. Acute G1 genitourinary toxicity was recorded in 37.5% and grade 2 in 15% of the patients. Only G1 acute gastrointestinal toxicity was recorded in 40% of the patients. CONCLUSIONS: Acute G1 genitourinary toxicity was experienced by a similar percentage of patients in both treatment arms. Acute G2 genitourinary toxicity was more frequent in the three-dimensional conformal radiotherapy arm. Higher acute genitourinary toxicity, G3 or G4, was recorded only in one patient per treatment arm. Acute gastrointestinal toxicity was more frequent in the three-dimensional conformal radiotherapy arm. Higher acute gastrointestinal toxicity, G2 and G3, was only observed in the three-dimensional conformal radiotherapy arm. The acute toxicity observed was of a low grade. The combination of external beam radiotherapy with brachytherapy resulted in a lower incidence of gastrointestinal toxicity than external beam radiotherapy alone.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07527065
- 003
- CZ-PrNML
- 005
- 20111210143539.0
- 008
- 090809s2007 it e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Soumarová, Renata $7 xx0031806
- 245 10
- $a Three-dimensional conformal external beam radiotherapy versus the combination of external radiotherapy with high-dose rate brachytherapy in localized carcinoma of the prostate: comparison of acute toxicity / $c Soumarová R, Homola L, Perková H, Stursa M
- 314 __
- $a JG Mendel Cancer Center Nový Jicín, Hospital Nový Jicín, Czech Republic. renata.soumarova@radioterapie.cz
- 520 9_
- $a AIMS AND BACKGROUND: Radiotherapy represents one of the basic therapeutic methods in treatment of localized carcinoma of the prostate. Optimal irradiation dose is the cornerstone of a successful treatment. Along with local control of the disease and overall survival of the patient, possible acute and long-term side effects need to be monitored very closely. METHODS: A non-randomized prospective study comparing the acute genitourinary and gastrointestinal toxicity in patients irradiated for localized carcinoma of the prostate. Fifty-seven patients were treated with three-dimensional conformal external beam radiotherapy alone, and in the second treatment arm a combination of external beam radiotherapy and high-dose rate brachytherapy was employed in 40 patients. RESULTS: Three-dimensional conformal external beam radiotherapy. Acute G1 genitourinary toxicity was recorded in 35.1% of patients, G2 in 22.8%, and G2-3 in one patient (1.7%). Acute gastrointestinal toxicity was experienced by 54.4% of patients, G1 in 28.1%, G2 in 17.5%, and G3 in 8.8%. Three-dimensional conformal external beam radiotherapy + brachytherapy. Acute G1 genitourinary toxicity was recorded in 37.5% and grade 2 in 15% of the patients. Only G1 acute gastrointestinal toxicity was recorded in 40% of the patients. CONCLUSIONS: Acute G1 genitourinary toxicity was experienced by a similar percentage of patients in both treatment arms. Acute G2 genitourinary toxicity was more frequent in the three-dimensional conformal radiotherapy arm. Higher acute genitourinary toxicity, G3 or G4, was recorded only in one patient per treatment arm. Acute gastrointestinal toxicity was more frequent in the three-dimensional conformal radiotherapy arm. Higher acute gastrointestinal toxicity, G2 and G3, was only observed in the three-dimensional conformal radiotherapy arm. The acute toxicity observed was of a low grade. The combination of external beam radiotherapy with brachytherapy resulted in a lower incidence of gastrointestinal toxicity than external beam radiotherapy alone.
- 650 _2
- $a adenokarcinom $x radioterapie $7 D000230
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a brachyterapie $x škodlivé účinky $7 D001918
- 650 _2
- $a gastrointestinální trakt $x účinky záření $7 D041981
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nádory prostaty $x radioterapie $7 D011471
- 650 _2
- $a celková dávka radioterapie $7 D011879
- 650 _2
- $a konformní radioterapie $x škodlivé účinky $7 D020266
- 650 _2
- $a urogenitální systém $x účinky záření $7 D014566
- 655 _2
- $a klinické zkoušky $7 D016430
- 655 _2
- $a srovnávací studie $7 D003160
- 700 1_
- $a Homola, Luboš, $d 1965- $7 mzk2007401226
- 700 1_
- $a Perková, Hana $7 xx0135659
- 700 1_
- $a Štursa, Miroslav $7 xx0139432
- 773 0_
- $w MED00010709 $t Tumori $g Roč. 93, č. 1 (2007), s. 37-44 $x 0300-8916
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20090726182400 $b ABA008
- 991 __
- $a 20090810052914 $b ABA008
- 999 __
- $a ok $b bmc $g 671059 $s 530232
- BAS __
- $a 3
- BMC __
- $a 2007 $b 93 $c 1 $d 37-44 $i 0300-8916 $m Tumori $x MED00010709
- LZP __
- $a 2009-B3/vtme